Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Iminothiazolidinones as inhibitors of HCV replication

Iminothiazolidinones as inhibitors of HCV replication

US Patent 7183302 · Granted Feb 27, 2007

Estimated economic value: $34,453,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cereblon ligands and bifunctional compounds comprising the same2025
Compounds and methods for the targeted degradation of androgen receptor2025
Compounds and methods for the targeted degradation of androgen receptor and asso2025
Mouse comprising a humanized TRKB locus2025
Compositions and methods for treating severe constipation2025
Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflamm2025
Modulators of BCL6 proteolysis and associated methods of use2025
Compounds and methods for the targeted degradation of androgen receptor2025
Compounds and methods for the enhanced degradation of targeted proteins2025
Cereblon ligands and bifunctional compounds comprising the same2025
Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of med2024
Macrocyclic fluorine substituted indole derivatives2024